What I do at MMV:
My role focuses on using SCID combination studies to look at the combined action of compounds. Using these data and human pharmacodynamics/pharmacokinetics information, we can predict how combinations might work in humans, which allows unbiased prioritization of optimal drug combinations for further research.
Why I work at MMV:
I became interested in infectious diseases and more particularly in malaria over the course of my studies and personal experiences in Africa. I joined MMV because I believe in the mission and want to contribute to developing and delivering affordable drugs to people that urgently need them. I think this is the starting point to aiding in the improvement of health, education, economic and social development of developing countries.
More about me:
I am a chemist by training and I have a PhD from the University Pierre and Marie Curie in Immunology and Parasitology, with a focus on malaria vaccine development and understanding the mechanisms used by the parasite to escape the host immune system. Before I started my PhD programme and for my own edification in Plasmodium behavior, I went to the University of Yaoundé in Cameroon to gain experience in the field with clinical and epidemiology techniques. I was involved in various research projects such as the effectiveness of sulfadoxine-pyrimethamine (SP) treatment in preventing malaria during pregnancy, in vitro determinationof P. falciparum field isolates sensitivity to antimalarials and in vivo evaluation of plant extracts activity to kill the Anopheles mosquito’s larvae.
Ask me about:
Any aspect of malaria, vaccines and mouse models. Aside from science, I am always motivated to go for a run or a swim… or a trip to Africa, where my heart is.